Publication | Open Access
Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients
43
Citations
30
References
2020
Year
Pretreatment NLR and mGPS might be predictive markers of survival in patients with R/M SCCHN treated with nivolumab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1